-
Netflix Analysts Have Wide-Ranging Reactions To Q1 Report
Wednesday, April 17, 2019 - 1:30pm | 691Read More...The analysts covering Netflix Inc. (NASDAQ; NFLX) stock this week are much like a big family trying to figure out what to watch on the streaming service. Some are leaning strongly Bull (Durham) and a few are vociferously arguing for (Paddington) Bear. In between, there's some romance...
-
Oppenheimer Comments on Management Outlook at Clorox
Thursday, August 11, 2011 - 7:18am | 74Read More...Oppenheimer has published a research report on Clorox (NYSE: CLX). In the report, Oppenheimer wrote, "Throughout our recent meeting, Clorox senior management expressed optimism regarding its momentum exiting fiscal 2011, and that its two primary headwinds—market growth and commodity costs—are...
-
Oppenheimer Initiates Derma Sciences At Outperform, $21 PT
Wednesday, July 6, 2011 - 6:57am | 24Read More...Oppenheimer has initiated coverage on Derma Sciences (NASDAQ: DSCI) with an Outperform rating and $21 price target.
-
Oppenheimer Raises PT On LMI Aerospace To $24
Monday, March 14, 2011 - 8:10am | 28Read More...Oppenheimer has raised the price target on LMI Aerospace (NASDAQ: LMIA) from $21 to $24 and maintains its Outperform rating.
-
Clearwire Plans To Sell Spectrum
Thursday, October 14, 2010 - 8:22am | 118Read More...Oppenheimer recently reported the news of the day, that was Clearwire's (NASDAQ: CLWR) plans to auction some of its spectrum for what it believes will be in the $3B range. It thinks the likeliest winner in this auction would be T-Mobile, which needs spectrum for 4G services. Regardless, closing...
